Speculative biotech shorts weighed on this hedge fund’s resultsMichelle Jones
Sio Partners was down 4.8% net for September, compared to the S&P 500 Total Return Index's decline of 3.8%, the MSCI World Healthcare Index's 1.5% decline, and the MSCI World Index's 3.6% decline. Sio's long positions detracted 2.4% during September, while its shorts detracted 2.3%.
A difficult September
In his September letter to investors, which . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.